|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
0.95/2.24
|
Enterprise Value
12.35B
|
Balance Sheet |
Book Value Per Share
13.46
|
Cash Flow |
Cash Flow Yield
0.03
|
Income Statement |
Total Revenue
1.16B
|
Operating Revenue Per Share
7.20
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/12 03:46 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%. |